Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 23 | $4,485,729 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Aug 2024 18:39 | RGNX | REGENXBIO Inc | SIMPSON CURRAN | Chief Executive Officer | 01 Aug 2024 | Sale | 100 | 15 | 1,500 | D |
05 Aug 2024 18:39 | RGNX | REGENXBIO Inc | KARABELAS ARGERIS N | Director | 01 Aug 2024 | Sale | 100 | 15 | 1,500 | D |
18 Jul 2024 17:05 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | Director | 16 Jul 2024 | Sale | 200 | 13.76 | 2,752 | D |
05 Aug 2024 18:39 | RGNX | REGENXBIO Inc | KARABELAS ARGERIS N | Director | 01 Aug 2024 | Sale | 400 | 14.585 | 5,834 | D |
04 Sep 2024 20:20 | RGNX | REGENXBIO Inc | KARABELAS ARGERIS N | Director | 03 Sep 2024 | Sale | 700 | 12.34 | 8,638 | D |
18 Jul 2024 17:05 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | Director | 17 Jul 2024 | Sale | 2,210 | 13.7737 | 30,440 | D |
05 Jan 2023 16:06 | RGNX | REGENXBIO Inc | PAKOLA STEVE | Chief Medical Officer | 03 Jan 2023 | Sale | 3,138 | 22.1668 | 69,559 | D |
16 Feb 2024 18:28 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | President and CEO | 14 Feb 2024 | Sale | 4,652 | 16.4716 | 76,626 | D |
04 Sep 2024 20:20 | RGNX | REGENXBIO Inc | KARABELAS ARGERIS N | Director | 03 Sep 2024 | Sale | 9,300 | 11.5 | 106,950 | D |
03 Jul 2024 07:55 | RGNX | REGENXBIO Inc | KARABELAS ARGERIS N | Director | 01 Jul 2024 | Sale | 10,000 | 11.2691 | 112,691 | D |
05 Aug 2024 18:39 | RGNX | REGENXBIO Inc | KARABELAS ARGERIS N | Director | 01 Aug 2024 | Sale | 9,600 | 13.45 | 129,120 | D |
30 Jul 2024 17:01 | RGNX | REGENXBIO Inc | SIMPSON CURRAN | Chief Executive Officer | 29 Jul 2024 | Sale | 9,648 | 15.04 | 145,106 | D |
30 Jul 2024 17:01 | RGNX | REGENXBIO Inc | KARABELAS ARGERIS N | Director | 29 Jul 2024 | Sale | 11,000 | 15.045 | 165,495 | D |
26 Jul 2024 17:00 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | Director | 24 Jul 2024 | Sale | 12,221 | 13.7823 | 168,433 | D |
16 Feb 2024 18:28 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | President and CEO | 14 Feb 2024 | Sale | 10,348 | 16.8847 | 174,723 | D |
26 Jul 2024 17:00 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | Director | 25 Jul 2024 | Sale | 15,369 | 13.9567 | 214,501 | D |
16 May 2024 17:06 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | President and CEO | 14 May 2024 | Sale | 15,000 | 15.8148 | 237,222 | D |
17 Apr 2024 17:05 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | President and CEO | 15 Apr 2024 | Sale | 15,000 | 18.1914 | 272,871 | D |
04 Jan 2024 16:23 | RGNX | REGENXBIO Inc | PAKOLA STEVE | Chief Medical Officer | 03 Jan 2024 | Sale | 17,237 | 17.3922 | 299,789 | D |
18 Mar 2024 17:03 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | President and CEO | 14 Mar 2024 | Sale | 15,000 | 21.8628 | 327,942 | D |
07 Mar 2024 18:05 | RGNX | REGENXBIO Inc | PAKOLA STEVE | Chief Medical Officer | 05 Mar 2024 | Sale | 12,878 | 28.36 | 365,220 | D |
18 Jan 2024 18:39 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | President and CEO | 16 Jan 2024 | Sale | 45,000 | 15.1776 | 682,992 | D |
21 Dec 2023 13:38 | RGNX | REGENXBIO Inc | MILLS KENNETH T. | President and CEO | 19 Dec 2023 | Sale | 45,000 | 19.685 | 885,825 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)